Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicky Fyfe"'
Autor:
Mairi H McLean, Graeme I Murray, Keith N Stewart, Gillian Norrie, Claus Mayer, Georgina L Hold, John Thomson, Nicky Fyfe, Mairi Hope, N Ashley G Mowat, Janice E Drew, Emad M El-Omar
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e15366 (2011)
Colorectal cancer (CRC) is a major cause of mortality and morbidity worldwide. Inflammatory activity within the stroma of invasive colorectal tumours is known to be a key predictor of disease activity with type, density and location of immune cells i
Externí odkaz:
https://doaj.org/article/863f15f9d20a41e495842957487aff62
Autor:
Suhaida A Selamat, Janice S Galler, Amit D Joshi, M Nicky Fyfe, Mihaela Campan, Kimberly D Siegmund, Keith M Kerr, Ite A Laird-Offringa
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21443 (2011)
BackgroundAberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarc
Externí odkaz:
https://doaj.org/article/b2eb146cafaf44aa9752ec800a46f547
Autor:
Ite A. Laird-Offringa, Janice S. Galler, Suhaida A. Selamat, M. Nicky Fyfe, Amit Joshi, Kimberly D. Siegmund, Mihaela Campan, Keith M. Kerr
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21443 (2011)
PLoS ONE
PLoS ONE
BackgroundAberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarc
Publikováno v:
Journal of clinical pathology. 57(4)
Aims: To discover whether variations in thyroid transcription factor 1 (TTF-1) staining in different subtypes and patterns of pulmonary adenocarcinoma are related to the putative origin of the tumour. In addition, to confirm the specificity of TTF-1
Autor:
Salmah Bakar, Matthew S. Lyall, Marianne Nicolson, Keith M. Kerr, Stuart C. Thomas, Nicky Fyfe
Publikováno v:
Journal of Thoracic Oncology. (8):S801-S802